ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 70 filers reported holding ATEA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 3.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,746,699 | -18.6% | 582,233 | +1.4% | 0.00% | 0.0% |
| Q2 2023 | $2,146,607 | +21.7% | 573,959 | +9.0% | 0.00% | 0.0% |
| Q1 2023 | $1,763,269 | -35.1% | 526,349 | -6.8% | 0.00% | 0.0% |
| Q4 2022 | $2,715,216 | -13.8% | 564,494 | +2.0% | 0.00% | 0.0% |
| Q3 2022 | $3,149,000 | +3.7% | 553,324 | +29.4% | 0.00% | 0.0% |
| Q2 2022 | $3,037,000 | +1.4% | 427,721 | +3.2% | 0.00% | 0.0% |
| Q1 2022 | $2,994,000 | -15.3% | 414,597 | +4.9% | 0.00% | 0.0% |
| Q4 2021 | $3,534,000 | -74.4% | 395,247 | +0.5% | 0.00% | -80.0% |
| Q3 2021 | $13,785,000 | +226.8% | 393,179 | +100.3% | 0.01% | +400.0% |
| Q2 2021 | $4,218,000 | -23.1% | 196,339 | +121.0% | 0.00% | -50.0% |
| Q1 2021 | $5,486,000 | +51.9% | 88,840 | +2.8% | 0.00% | +100.0% |
| Q4 2020 | $3,612,000 | – | 86,434 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $4,712,400 | 33.11% |
| BML Capital Management, LLC | 2,236,239 | $8,363,534 | 7.52% |
| TANG CAPITAL MANAGEMENT LLC | 3,026,455 | $11,318,942 | 1.67% |
| Stonepine Capital Management, LLC | 752,088 | $2,812,809 | 1.02% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $9,296,286 | 0.96% |
| CM Management, LLC | 250,000 | $935 | 0.91% |
| EcoR1 Capital, LLC | 6,995,861 | $26,164,520 | 0.64% |
| Cormorant Asset Management, LP | 1,547,181 | $5,786,457 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 501,537 | $1,875,748 | 0.31% |
| Auour Investments LLC | 177,000 | $661,980 | 0.28% |